MEI, BeiGene to assess ME-401-Zanubrutinib combo in B-cell malignancies

Image: MEI, BeiGene announce clinical collaboration to evaluate ME-401-Zanubrutinib combo. Photo: courtesy of ponsulak/Freedigitalphotos.net.